Effect of curcumin in prevention of pre-invasive lesions of the cervix
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20171410Keywords:
Cervical intraepithelial neoplasia, Chemoprevention, Curcumin, Epidemiology, Risk factors, ScreeningAbstract
Background: Cervical cancer is the leading cause of deaths of women due to malignancies in developing countries world-wide. Having a latency period of upto10 years, pre-invasive lesions of cervix give us a wide margin for detection and treatment before it becomes cancerous. It has been estimated that even after putting in all the resources it’s not possible to screen one fourth of the population of women in India. This is the aim of this study to establish a pattern of prevalence of these pre-invasive lesions and find out correlation with various epidemiological factors and establish best screening modality in low resourse settings like ours. Curcuminoids are the extract of curcuma longa, and it has been found to have myriad effects like anti-inflammatory, antibiotic, and anti-cancerous as well. In this study we have tried to determine its effect on precancerous lesions of the cervix.
Methods: In this study, patients coming to the OPD of the Gynaecology Department with various complaints like vaginal discharge and post coital bleeding etc were subjected to en VIA examination (visual inpection with acetic acid), and cytology. Selected cases were subjected to colposcopy and biopsy, which is taken as gold standard in the study. The cases were studied in terms of their epidemiologic charecterestics. The diagnostic accuracy of VIA and cytology was assessed using colposcopy and biopsy as the gold standard, chi square test applied and power of the screening test calculated.
Results: 226 cases were subjected to VIA examination, using freshly prepared 5% acetic acid .105(46.5%) cases were VIA positive. Same no of cases were also subjected to cytological evaluation. Upon cytological evaluation, 21(9.3%) had a normal cytology, 158(69.9%) were inflammatory, 3(1.3%) had ASCUS, 1(0.4%) had AGUS, 26(11.6%) had LSIL and koilocytic changes, 11(4.9%) had HSIL, and 6 cases (2.6%) had squamous cell carcinoma. Abnormal cytology (47/226) was mostly found in age group 30-40 29/47 (61.7%), were para 2 to 4 34/47 (72.3%), belonged to class IV-V socioeconomic class 28(59.6%), belonged to rural areas 32/47(68%) were illiterate 29/47(61.7%) were married at a young age 15-17 23/47(49%) and were not using any contraception 22/47(46.8%).
Conclusions: Cervical cancer being one of the most easily preventable cancer owing to the easy accessibility of the cervix to the clinician, and easy screening methods available, is amenable to eradication of the disease one day.
Metrics
References
IARC Globocan; 2008. Available from: http://www.iarc.fr/en/mediacentre/iarcnews/2010/globocan2008.php.
Van GJ, Ortmarssen O, Habbema JD. Epidemiological evidence for age- dependent regression of preinvasice cervical cancer. Br J Cancer. 1991;64(3):559-65.
Aswathy S, Quereshi MA, Kurian B, Leelamoni K. Cervical cancer screening: current knowledge and practice among women in rural population of kerala, India. Indian J Med Res. 2012;136:205-10.
Aggarwal BB, Bhatt ID, Ichikawa H, Ahn KS, Sethi G, Sandur SK, et al. Curcumin- biological and medicinal properties in P.N. Ravindran, K.N. Babu, K. Sivaramab (Eds.), Turmeric the Genus Curcuma, CRC Press , NY, 2007:297-368.
Chen H, Zang ZS, Zang YL. Curcumin inhibits cell proliferation by interfering with the cell cycle and inducing apoptosis in colon carcinoma cell lines. Anticancer Res. 1999;19:3675-80.
Tsuji M, Kawano S. Tsuji S. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell. 1998;9:705-16.
Pillai MR. Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis. 2006;45(5):320-32.
Sela GB, Epelbaum R, Schaffer M. Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications. Curr Medicinal Chem. 2010;17:1.
Aggarwal R, Gupta S, Nijhawan R, Suri V, Aur A, Bhasin V, et al. Prevalence of high - risk human papillomavirus infections in women with benign cervical cytology: a hospital based study from North India. Indian J Cancer. 2006;43:3.
Appleby P, Beral V, Gonzalez A, Colin D, Franceschi S, Goodhill A, et al. Cervical cancer and hormonal contraceptives: collaborative reanalysis of indivisual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies. Lancet. 2007;370(9599):1609-21.
Harris V, Sandridge AL, Black RJ, Brewster DH, Gould A, cancer registration statistics: Scotland, Edinburgh: ISD Scotland publications; 1986-1995:9-10.
Lindau ST, Tomori C, Lyons T, Langseth L, Bennet CL, Garcia P. The association of health literacy with cervical cancer prevention knowledge and health behaviours in a multiethnic cohort of women. AJOG. 2002;186(5):938-43.
Stone KM, Zaidi A, Bixby L, Oberle MW, Reynolds G, Larsen S, et al. Sexual behaviour, sexually transmitted diseases and risk of cervical cancer. Epidemiol. 1995;6:409-14.
Nanda K, Mccrory DC, Meyers ER. Accuracy of papanicolaou test in screening for and follow up of cervical cytologic abnormalities. Ann Intern Med. 2000;132(10):810-9.
Ardahan M, Temel, Alya B. Visual inspection with acetic acid in cervical cancer screening. Cancer Nurs. 2011;34:58-163.
Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, et al. Phase 1 clinical trial of curcumin, a chemo preventive agent, in patients with high risk or pre malignant lesions. Anticancer Res. 2001;21(4):2895-900.
Venkatraman M, Anto RJ, Nair A, Varghese M, Karunagaran D. Biological band chemical inhibitors of NF kappa B sensitize sia cells to cisplatin – induced apoptosis. Mol Carcinogen. 2005;44:51-9.
Melinkow J, Nuovo J, Willian AR. Natural history of cervical squamous intraepithelial lesions: a metaanalysis. Obst Gynaecol. 1998;92(4):727-35.
Shankar T, Shantha NV, Ramesh HP, Murthy IA, Murthy VS. Toxicity studies on turmeric (Curcuma longa): acute toxicity studies in rats, guinea pigs and monkeys. Indian J Exp Biol. 1980;18:73-5.
Nci D. Clinical development plan: curcumin. J Cell Biochem Suppl. 1996;26:72-85.
Deodhar SD, Sethi R, Srimal RC. Preliminary study on antirheumatic activity of curcumin (diferuloyl methane). Indian J Med Res. 1980;71:632-4.
Wungki P, Amin R, Georgia ZC, Shin DM. New perspectives of curcumin in cancer prevention. Department of Hematology and Medical Oncology. Winship Cancer Institute of Emory University, Atlanta, Georgia, Cancer Prev Res. 2013;6(5):387-400.
Downloads
Published
How to Cite
Issue
Section
